Hsbc Holdings PLC Takes Position in Astrana Health, Inc. $ASTH

Hsbc Holdings PLC purchased a new stake in Astrana Health, Inc. (NASDAQ:ASTH) during the first quarter, according to its most recent filing with the SEC. The firm purchased 6,525 shares of the company’s stock, valued at approximately $200,000.

A number of other institutional investors and hedge funds have also made changes to their positions in ASTH. Vanguard Group Inc. increased its holdings in shares of Astrana Health by 4.5% in the 1st quarter. Vanguard Group Inc. now owns 4,898,992 shares of the company’s stock valued at $151,918,000 after acquiring an additional 213,033 shares during the period. Nuveen LLC purchased a new position in shares of Astrana Health in the 1st quarter valued at $3,369,000. Diamond Hill Capital Management Inc. increased its holdings in shares of Astrana Health by 32.6% in the 1st quarter. Diamond Hill Capital Management Inc. now owns 211,038 shares of the company’s stock valued at $6,544,000 after acquiring an additional 51,827 shares during the period. Northern Trust Corp increased its holdings in shares of Astrana Health by 10.1% in the 4th quarter. Northern Trust Corp now owns 467,179 shares of the company’s stock valued at $14,730,000 after acquiring an additional 43,032 shares during the period. Finally, Jacobs Levy Equity Management Inc. increased its holdings in shares of Astrana Health by 105.3% in the 4th quarter. Jacobs Levy Equity Management Inc. now owns 76,346 shares of the company’s stock valued at $2,407,000 after acquiring an additional 39,156 shares during the period. 52.77% of the stock is currently owned by hedge funds and other institutional investors.

Astrana Health Stock Down 3.6%

Shares of ASTH stock opened at $29.70 on Friday. Astrana Health, Inc. has a 1-year low of $21.20 and a 1-year high of $63.20. The stock’s fifty day moving average price is $26.48 and its 200 day moving average price is $28.21. The company has a debt-to-equity ratio of 0.52, a current ratio of 1.59 and a quick ratio of 1.59. The company has a market cap of $1.66 billion, a price-to-earnings ratio of 58.24, a price-to-earnings-growth ratio of 0.77 and a beta of 0.85.

Astrana Health (NASDAQ:ASTH) last announced its earnings results on Thursday, August 7th. The company reported $0.19 earnings per share for the quarter, missing the consensus estimate of $0.36 by ($0.17). Astrana Health had a return on equity of 3.43% and a net margin of 1.04%.The business had revenue of $654.81 million for the quarter, compared to analysts’ expectations of $639.13 million. During the same quarter last year, the firm earned $0.40 earnings per share. The firm’s quarterly revenue was up 34.7% compared to the same quarter last year. Astrana Health has set its Q3 2025 guidance at EPS. On average, research analysts expect that Astrana Health, Inc. will post 1.15 earnings per share for the current fiscal year.

Analyst Ratings Changes

Separately, Zacks Research downgraded Astrana Health from a “strong-buy” rating to a “strong sell” rating in a report on Monday, September 1st. Six equities research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $53.29.

Astrana Health Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.